{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122 Automated Microbiology System - Ampicillin-sulbactam",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent ampicillin-sulbactam (1/0.5-32/16 \u03bcg/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K071623",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K043389",
        "K061327"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "August 20, 2007",
    "Summary Letter Received Date": "June 14, 2007",
    "Submission Date": "June 13, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ampicillin-sulbactam"
    ],
    "Specimen Type(s)": [
        "Pure culture of most aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution test",
        "Redox indicator detection",
        "Automated susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Organism identification (ID)",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent",
        "Instrument",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System panels with ampicillin-sulbactam for automated antimicrobial susceptibility and identification testing of bacterial isolates",
    "Indications for Use Summary": "Intended for rapid identification and in vitro quantitative antimicrobial susceptibility testing (MIC determination) of Gram-negative and Gram-positive bacteria isolates from pure culture, including Enterobacteriaceae, Non-Enterobacteriaceae, Staphylococcus, Enterococcus, and Streptococcus, using Phoenix panels containing ampicillin-sulbactam",
    "fda_folder": "Microbiology"
}